Search results
Newswise Expert | Puneeth Iyengar, UT Southwestern Medical Center
Newswise· 3 days agoBriefly, Puneeth Iyengar joined the UT Southwestern Medical Center in Dallas, TX USA in the summer of 2010 and is currently an Assistant Professor of Radiation Oncology, with a professional ...
Newswise Expert | Suzanne Cole, UT Southwestern Medical Center
Newswise· 3 days agoSuzanne Cole, M.D., is a medical oncologist at UT Southwestern Medical Center. She serves as the Medical Director of the&a
Lack of Insurance Keeps Many Americans From Best Cancer Meds
US News & World Report· 5 days agoA cutting-edge class of drugs is saving and extending the lives of cancer patients. New policies are needed "to improve health insurance coverage options and to make new treatments ...
Lack of insurance may prevent Americans from accessing best cancer drugs
UPI· 5 days agoAmong patients diagnosed with advanced melanomas, those who had private health insurance saw rates...
A human-performance scientist shares the 9 supplements he takes daily for gut, brain, and muscle...
INSIDER via Yahoo News· 4 days agoProfessor Andy Galpin, whose clients include the LA Clippers and Travis Barker, adjusts his daily...
How 7 health systems are spending donations
Becker’s Hospital Review· 4 days agoMark Keroack, MD, president and CEO of Springfield, Mass.-based Baystate Health, and his wife, Ann Errichetti, MD, have created an endowed fund to support ...
‘Whew. He didn’t say avoid Diet Coke’: Cancer doctor shares the 5 things he ‘would never do’
The Daily Dot· 3 days agoA popular oncology dietician just took her followers with her to the grocery store to show them...
...anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Pancreatic Cancer or Biliary Tract Cancer -...
Benzinga· 6 days agoSAN FRANCISCO, U.S. and SUZHOU, China , June 1, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes
Live from ASCO 2024 | Ascentage Pharma Releases Updated Data of FAK/ALK/ROS1 Inhibitor APG-2449 in...
Benzinga· 6 days agoSUZHOU, China, and ROCKVILLE, Md., June 1, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for < ...
Nanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With...
Benzinga· 6 days agoData show favorable safety and feasibility in 68 heavily pre-treated patients with R/M-HNSCC (Intention-to-Treat population; "ITT") who received RT-activated NBTXR3 followed by anti-PD-1 as a second-or-later line